Labels

Lifestyle (460) Investing (404) Entertainment (305) Singapore (262) Technology (150) Rewards (137) Insights (129) Gaming (105) Equities (97) AI (90) Data (86) Food (85) U.S. (77) Sports (74) Crypto (73) Travel (66) Portfolio (55) News (51) Credit Card (38) Earnings (36) Football (35) Movies (35) Savings (34) Property (29) Policies (27) Tennis (25) Shows (24) Holidays (23) Promotions (19) Bonds (16) Toys (16) Malaysia (15) World (15) REITs (14) T-Bills (12) Apps (11) China (11) Healthcare (10) Referral (10) Currency (9) Anime (8) DeFi (8) Retirement (8) CPF (7) Cash Management (7) Security (6) ETFs (5) Miles (5) Shopping (5) Commodities (4) Robotics (4) Weird (4) platform (4) Cashback (3) Insurance (3) Japan (3) Blog (2) Reviews (2) Robo-Advisor (2) 1-For-1 (1) Asia (1) Australia (1) Banking (1) Funds Management (1) Futuristic (1) Government (1) Indonesia (1) Inflation (1) Interesting (1) Nerfs (1) SGD (1) SSB (1) Social (1) Thailand (1)

Wednesday, 7 October 2026

Investing Updates: New ETFs Coming to SGX: S&P 500, NASDAQ-100 and MSCI World Explained


Source:



ChatGPT:


This is a meaningful development for Singapore ETF investors, and the online reaction is noticeably more substantive than the headline might suggest. The key issue isn't simply "four new ETFs"; it's whether SGX-listed, SGD-traded, Ireland-domiciled UCITS ETFs can become a practical alternative to buying CSPX/VWRA/etc. through LSE/IBKR.

πŸ“° Article summary

The Smart Investor's 6 October article covers four Xtrackers UCITS ETFs from DWS that are scheduled to begin trading on SGX on 13 October 2026. (The Smart Investor)

SGX tickerExposureTERMain attraction
XUSS&P 5000.03%Very cheap US large-cap exposure
EUSS&P 500 Equal Weight0.15%Reduces mega-cap concentration
XNDNasdaq-1000.20%Tech/growth-heavy exposure
XWRMSCI World0.12%Developed-market diversification

All four are Irish-domiciled, accumulating UCITS ETFs, meaning dividends are reinvested rather than distributed. (The Smart Investor)

The headline attraction is that Singapore investors can now buy them in SGD on SGX, rather than accessing the LSE and converting SGD → USD/GBP first.

The tax angle is particularly important

The article argues that Ireland-domiciled ETFs are generally more tax-efficient for Singapore investors than US-domiciled ETFs.

For example, it compares:

S27 — US-domiciled S&P 500 ETF

vs.

XUS — Ireland-domiciled S&P 500 ETF

The article estimates that the combination of lower TER and lower dividend withholding-tax drag could save roughly 0.23 percentage points annually, or around S$230 per year on S$100,000 invested, based on its assumptions. (The Smart Investor)

That's potentially significant over decades.


πŸ”₯ But there's a much bigger story than the article

The real question being discussed online is:

"Should I now buy XUS/XWR on SGX instead of CSPX/VWRA through IBKR?"

And the answer from the investing community is basically:

Maybe — but don't sell your existing ETFs just to switch.

That's the dominant theme I've found.


πŸ’¬ Reddit reaction

This is where the discussion is strongest.

The original r/singaporefi thread announcing the ETFs received 63 upvotes, with substantial discussion around:

  • XUS vs CSPX

  • XWR vs VWRA

  • SRS eligibility

  • SGX vs LSE trading

  • broker fees

  • liquidity

  • bid/ask spreads

  • CDP

  • SGD trading

  • currency risk. (Reddit)

That captures the sentiment quite well.

🟒 What's exciting investors

1. SRS

This may be the biggest practical advantage.

If you're investing through SRS, an SGX-listed ETF provides a much easier route to global equities than going through an overseas exchange. Redditors specifically highlighted the attraction of using XUS/XWR for SRS. (Reddit)

2. SGD trading

No need to manually convert SGD into USD before buying.

But there's an important misconception:

SGD-traded ≠ SGD-hedged.

XUS can be bought in SGD, but you're still exposed to the underlying US stocks and their currencies. (Reddit)

3. Ireland domicile

This retains the key tax advantage that Singapore investors already seek when buying CSPX/VWRA through the LSE. (Reddit)

4. Extremely low XUS TER

At 0.03%, XUS is unusually cheap.

That's even lower than CSPX's 0.07%. (The Kopi Notes)


⚠️ The biggest concern: liquidity

This is probably the single most important criticism.

CSPX has been trading on the LSE for years and has enormous liquidity.

The new Xtrackers SGX counters are starting from scratch on the Singapore trading line.

HardwareZone investors have already raised precisely this concern.

One HWZ discussion notes that S27 has substantially longer trading history and liquidity, while existing Xtrackers SGX listings such as XSG have relatively low volume. (HardwareZone Forums)

So:

XUS TER: 0.03%
CSPX TER: 0.07%

looks fantastic on paper.

But if XUS consistently has a materially wider bid/ask spread, that 0.04% TER advantage can become less meaningful.

That's why I would not automatically declare XUS superior to CSPX yet.

We need to see actual trading volume and spreads after 13 October.


πŸ–₯️ HardwareZone sentiment

The HWZ discussion is surprisingly balanced.

The overall attitude is:

πŸ‘ "This is good."

But followed immediately by:

πŸ€” "How liquid will it actually be?"

One HWZ participant described the growing ETF competition as good for retail investors, while another pointed out that investors shouldn't assume the new SGX ETFs will immediately match established LSE liquidity. (HardwareZone Forums)

Another very interesting HWZ discussion about XWR asks the obvious question:

Why not just have Vanguard cross-list VWRA?

That's telling.

VWRA remains the benchmark in many Singapore DIY portfolios.

XWR isn't equivalent to VWRA:

  • XWR = developed markets

  • VWRA = developed + emerging markets

So somebody moving from VWRA to XWR is actually changing their portfolio allocation, not merely changing the exchange. (HardwareZone Forums)


πŸ“Š Social-media / investing-community sentiment

I searched specifically for discussion around XUS/XWR/XND/EUS across the platforms you mentioned.

Reddit — 🟒 Strongly positive

This is currently the most active public discussion.

The tone is overwhelmingly:

"Interesting."
"Could be useful."
"Especially for SRS."
"Let's see the liquidity."

There is very little outright negativity. (Reddit)

HardwareZone — 🟒/🟑 Positive but pragmatic

More technically minded.

People are thinking about:

  • commissions

  • CDP

  • liquidity

  • bid/ask spreads

  • SRS

  • tax efficiency

  • broker selection.

This is probably the most useful discussion for actual Singapore investors. (HardwareZone Forums)

X / Twitter — 🟒 Positive but limited

There isn't yet a huge mainstream X conversation around the article itself.

The strongest social amplification is from the financial/investing ecosystem rather than ordinary retail investors.

Facebook — 🟑 Limited

I didn't find a significant public discussion specifically around this Smart Investor article.

Instagram — 🟑 Limited

Mostly informational/promotional content rather than detailed investor debate.

TikTok — 🟑 Limited

No meaningful volume of public discussion yet.

Threads — 🟑 Limited

Likewise, not enough discussion to suggest a strong independent sentiment.

Professional social media — 🟒 Strong

SGX itself is actively promoting the listing, emphasising SGD trading and SRS eligibility. (LinkedIn)

So the social-media picture is currently:

Investor forums >>> Reddit > professional social media >>> mainstream social media


🧠 The REALLY important comparison

For a Singapore investor, I'd frame the four ETFs like this:

ETFBest use
XUSCheap S&P 500 core
EUSReduce mega-cap concentration
XNDNasdaq/technology tilt
XWRDeveloped-world core
CSPXEstablished LSE S&P 500 option
VWRADeveloped + emerging global core

And XWR is not a VWRA replacement.

That's one of the biggest points being debated online.


πŸ’° What this means for your portfolio

This article is actually particularly relevant to your investment setup because you've previously looked at Amundi MSCI World, global portfolios, IBKR and Singapore-listed ETFs.

I wouldn't interpret this announcement as:

"Sell existing global ETFs and buy XUS/XWR."

I'd interpret it as:

"Singapore investors now have another potentially excellent accumulation route."

For new money, the calculation becomes much more interesting.

If you want S&P 500

XUS becomes very compelling.

0.03% TER + Ireland domicile + SGD trading + potentially SRS eligibility.

But wait for actual SGX liquidity.

If you want developed-world diversification

XWR is interesting, particularly for SRS/CDP-oriented investors.

But don't confuse it with VWRA.

If you already use IBKR

The advantage is less obvious.

IBKR gives you:

  • LSE access

  • very deep liquidity

  • cheap FX

  • enormous ETF selection.

So the convenience of SGX doesn't necessarily outweigh IBKR's advantages.


πŸ“ˆ My sentiment & impact scores

CategoryScore / 10
Overall sentiment8.5/10 positive
Retail investor excitement8/10
Reddit sentiment8.5/10
HardwareZone sentiment8/10
Controversy2/10
Investment significance9/10
Impact on SGX8/10
Impact on SRS investors9/10
Impact on existing IBKR investors6/10
Impact on beginner investors9/10
Immediate market impact5/10
Long-term significance9/10

⭐ Overall sentiment: 8.5/10 positive

⭐ Overall impact: 8.5/10

My verdict: This is more important than the Smart Investor article makes it sound.

The article is basically a useful explainer, but the underlying development could be one of the more significant improvements to Singapore's retail ETF landscape in years.

The biggest winners are probably:

πŸ₯‡ SRS investors
πŸ₯ˆ Beginners who want global exposure without LSE/FX complexity
πŸ₯‰ Investors who want CDP-held global ETFs

The people who gain the least are experienced IBKR + LSE investors, because CSPX/VWRA and similar ETFs already give them excellent access and liquidity.

And there's one thing I'd watch very closely on 13 October:

XUS's actual bid/ask spread and trading volume.

If XUS develops decent liquidity, its 0.03% TER + Ireland domicile + SGX/SRS accessibility makes it a genuinely serious competitor to CSPX for Singapore investors.

If liquidity is poor, CSPX remains the better practical instrument despite its slightly higher TER.

So I'd call this 8.5/10 impact — but with a big "watch the liquidity" asterisk.

No comments:

Post a Comment